This week, Actelion announced the first drug approved for the treatment of pediatric PH patients. Prior to the announcement, there were 14 FDA-approved PH treatments for adults living with the disease. PHA will work with its Scientific Leadership Council to provide families with answers to questions that the new announcement could raise about the care of their children who are living with PH.
